Biggest News Aggregation in the World
📰 Nasdaq Coll News

Page 5 - Nasdaq Coll News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Coll. Real-time updates on events, politics, business and more.

Collegium Pharmaceutical (COLL) to Release Earnings on Thursday

Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) is set to release its earnings data after the market closes on Thursday, May 4th. Analysts expect Collegium Pharmaceutical to post earnings of $1.26 per share for the quarter. Collegium Pharmaceutical has set its FY 2023 guidance at EPS.Persons interested in listening to the company’s earnings conference call can […]
Joseph Ciaffoni Scott Dreyer Piper Sandler Collegium Pharmaceutical Company Profile Capital Management Collegium Pharmaceutical Inc
Source: wkrb13.com

South Dakota Investment Council Purchases 7,725 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

South Dakota Investment Council grew its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) by 2.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 281,572 shares of the specialty pharmaceutical company’s stock after acquiring an additional 7,725 shares during […]
Los Angeles United States Colleen Tupper Joseph Ciaffoni Piper Sandler Exchange Commission

Collegium Pharmaceutical (NASDAQ:COLL) PT Lowered to $35.00 at Piper Sandler

Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) had its price target lowered by Piper Sandler from $37.00 to $35.00 in a research report released on Tuesday, The Fly reports. Other research analysts also recently issued research reports about the stock. StockNews.com began coverage on shares of Collegium Pharmaceutical in a research report on Thursday, March 16th. […]
Piper Sandler Joseph Ciaffoni Colleen Tupper Financial Services Group Inc Needham Company Altshuler Shaham Ltd

Collegium Pharmaceutical (NASDAQ:COLL) Given New $35.00 Price Target at Piper Sandler

Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) had its price objective cut by equities researchers at Piper Sandler from $37.00 to $35.00 in a research note issued to investors on Tuesday, The Fly reports. Piper Sandler’s price objective suggests a potential upside of 49.57% from the stock’s current price. A number of other equities research analysts […]
Piper Sandler Colleen Tupper Shirleyr Kuhlmann Collegium Pharmaceutical Inc Allspring Global Investments Holdings Needham Company
Source: wkrb13.com

Mesirow Institutional Investment Management Inc. Sells 89,831 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Mesirow Institutional Investment Management Inc. reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) by 23.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 290,534 shares of the specialty pharmaceutical company’s stock after selling 89,831 shares during the period. Mesirow […]
Colleen Tupper Piper Sandler Joseph Ciaffoni Collegium Pharmaceutical Company Profile S Capital Wealth Advisors Mesirow Institutional Investment Management Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Emerald Mutual Fund Advisers Trust Has $15.91 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Emerald Mutual Fund Advisers Trust cut its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) by 1.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 685,893 shares of the specialty pharmaceutical company’s stock after selling 9,500 shares during the period. […]
Colleen Tupper Shirleyr Kuhlmann Securities Exchange Commission Pricet Rowe Associates Inc Collegium Pharmaceutical Inc Emerald Mutual Fund Advisers

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by MetLife Investment Management LLC

MetLife Investment Management LLC cut its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) by 13.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 17,661 shares of the specialty pharmaceutical company’s stock after selling 2,676 shares during the period. MetLife Investment Management LLC owned […]
United States Joseph Ciaffoni Colleen Tupper Susquehanna Fundamental Investments Tejara Capital Ltd Needham Company
Source: wkrb13.com

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Recommendation of "Buy" from Analysts

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) has been given a consensus rating of “Buy” by the seven analysts that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have given a buy recommendation to the company. The […]
United States Piper Sandler Zacks Investment Research Oneascent Financial Services America Corp Oneascent Wealth Management

Analysts Anticipate Collegium Pharmaceutical, Inc. (NASDAQ:COLL) to Post $1.42 Earnings Per Share

Wall Street brokerages expect Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) to report earnings per share (EPS) of $1.42 for the current quarter, according to Zacks. Five analysts have made estimates for Collegium Pharmaceutical’s earnings, with estimates ranging from $1.25 to $1.75. Collegium Pharmaceutical reported earnings of $0.27 per share during the same quarter last […]
Hong Kong Piper Sandler Harel Insurance Investments Financial Services Ltd Zacks Investment Research Needham Company Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Average Recommendation of "Buy" by Brokerages

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) has been assigned a consensus rating of “Buy” from the seven brokerages that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the […]
United States Piper Sandler Scott Dreyer Securities Exchange Commission Principal Financial Group Inc Massachusetts Financial Services Co

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science